glp 1 osteoarthritis Targeting the GLP-1/GLP-1R axis to treat osteoarthritis: A new opportunity? Glucagon-Like Peptide-1 Receptor Agonists in
Description
Although not specifically approved for weight loss, it has shown promising results for this purpose, with many patients experiencing noticeable weight loss
It reduces inflammation
Semaglutide suppresses NLRP3 inflammasome activation, reduces proinflammatory cytokines and chemokines, and decreases adhesion molecules that attract immune cells to vessel walls
-1 Incretins have an important role in glucose homeostasis, regulation of appetite, energy expenditure and immunity
Researchers followed 173 patients with rheumatoid arthritis and a BMI of at least 27 who took semaglutide or tirzepatide, compared with 42 who were prescribed the medication but never started it
